TCN2 and cancer: Whole genome and exome sequencing associated six novel loci with serum B12 (CD320, TCN2, ABCD4, MMAA, MMACHC) or folate levels (FOLR3) with cardiovascular diseases, cancers, and neurodegenerative disorders